Copyright Reports & Markets. All rights reserved.

Global Sexual Dysfunction Drugs Market Research Report 2021

Request for Sample of this report
Buy now

1 Sexual Dysfunction Drugs Market Overview

  • 1.1 Product Overview and Scope of Sexual Dysfunction Drugs
  • 1.2 Sexual Dysfunction Drugs Segment by Type
    • 1.2.1 Global Sexual Dysfunction Drugs Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Oral Therapy
    • 1.2.3 Intracavernosal Therapy
    • 1.2.4 Hormonal Therapy
    • 1.2.5 Transurethral Therapy
  • 1.3 Sexual Dysfunction Drugs Segment by Application
    • 1.3.1 Sexual Dysfunction Drugs Sales Comparison by Application: (2021-2027)
    • 1.3.2 Male
    • 1.3.3 Female
  • 1.4 Global Sexual Dysfunction Drugs Market Size Estimates and Forecasts
    • 1.4.1 Global Sexual Dysfunction Drugs Revenue 2016-2027
    • 1.4.2 Global Sexual Dysfunction Drugs Sales 2016-2027
    • 1.4.3 Sexual Dysfunction Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Sexual Dysfunction Drugs Market Competition by Manufacturers

  • 2.1 Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Sexual Dysfunction Drugs Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Sexual Dysfunction Drugs Manufacturing Sites, Area Served, Product Type
  • 2.5 Sexual Dysfunction Drugs Market Competitive Situation and Trends
    • 2.5.1 Sexual Dysfunction Drugs Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Sexual Dysfunction Drugs Players Market Share by Revenue
    • 2.5.3 Global Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Sexual Dysfunction Drugs Retrospective Market Scenario by Region

  • 3.1 Global Sexual Dysfunction Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Sexual Dysfunction Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Sexual Dysfunction Drugs Market Facts & Figures by Country
    • 3.3.1 North America Sexual Dysfunction Drugs Sales by Country
    • 3.3.2 North America Sexual Dysfunction Drugs Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Sexual Dysfunction Drugs Market Facts & Figures by Country
    • 3.4.1 Europe Sexual Dysfunction Drugs Sales by Country
    • 3.4.2 Europe Sexual Dysfunction Drugs Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Sexual Dysfunction Drugs Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Sexual Dysfunction Drugs Sales by Region
    • 3.5.2 Asia Pacific Sexual Dysfunction Drugs Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Sexual Dysfunction Drugs Market Facts & Figures by Country
    • 3.6.1 Latin America Sexual Dysfunction Drugs Sales by Country
    • 3.6.2 Latin America Sexual Dysfunction Drugs Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Sexual Dysfunction Drugs Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Sexual Dysfunction Drugs Sales by Country
    • 3.7.2 Middle East and Africa Sexual Dysfunction Drugs Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Sexual Dysfunction Drugs Historic Market Analysis by Type

  • 4.1 Global Sexual Dysfunction Drugs Sales Market Share by Type (2016-2021)
  • 4.2 Global Sexual Dysfunction Drugs Revenue Market Share by Type (2016-2021)
  • 4.3 Global Sexual Dysfunction Drugs Price by Type (2016-2021)

5 Global Sexual Dysfunction Drugs Historic Market Analysis by Application

  • 5.1 Global Sexual Dysfunction Drugs Sales Market Share by Application (2016-2021)
  • 5.2 Global Sexual Dysfunction Drugs Revenue Market Share by Application (2016-2021)
  • 5.3 Global Sexual Dysfunction Drugs Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Pfizer
    • 6.1.1 Pfizer Corporation Information
    • 6.1.2 Pfizer Description and Business Overview
    • 6.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Pfizer Product Portfolio
    • 6.1.5 Pfizer Recent Developments/Updates
  • 6.2 GlaxoSmithKline
    • 6.2.1 GlaxoSmithKline Corporation Information
    • 6.2.2 GlaxoSmithKline Description and Business Overview
    • 6.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 GlaxoSmithKline Product Portfolio
    • 6.2.5 GlaxoSmithKline Recent Developments/Updates
  • 6.3 Merck
    • 6.3.1 Merck Corporation Information
    • 6.3.2 Merck Description and Business Overview
    • 6.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Merck Product Portfolio
    • 6.3.5 Merck Recent Developments/Updates
  • 6.4 Eli Lilly
    • 6.4.1 Eli Lilly Corporation Information
    • 6.4.2 Eli Lilly Description and Business Overview
    • 6.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Eli Lilly Product Portfolio
    • 6.4.5 Eli Lilly Recent Developments/Updates
  • 6.5 AbbVie
    • 6.5.1 AbbVie Corporation Information
    • 6.5.2 AbbVie Description and Business Overview
    • 6.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 AbbVie Product Portfolio
    • 6.5.5 AbbVie Recent Developments/Updates
  • 6.6 Bayer
    • 6.6.1 Bayer Corporation Information
    • 6.6.2 Bayer Description and Business Overview
    • 6.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Bayer Product Portfolio
    • 6.6.5 Bayer Recent Developments/Updates
  • 6.7 Teva Pharmaceutical Industries
    • 6.6.1 Teva Pharmaceutical Industries Corporation Information
    • 6.6.2 Teva Pharmaceutical Industries Description and Business Overview
    • 6.6.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Teva Pharmaceutical Industries Product Portfolio
    • 6.7.5 Teva Pharmaceutical Industries Recent Developments/Updates
  • 6.8 Takeda
    • 6.8.1 Takeda Corporation Information
    • 6.8.2 Takeda Description and Business Overview
    • 6.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Takeda Product Portfolio
    • 6.8.5 Takeda Recent Developments/Updates
  • 6.9 Apricus Biosciences
    • 6.9.1 Apricus Biosciences Corporation Information
    • 6.9.2 Apricus Biosciences Description and Business Overview
    • 6.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Apricus Biosciences Product Portfolio
    • 6.9.5 Apricus Biosciences Recent Developments/Updates
  • 6.10 Emotional Brain
    • 6.10.1 Emotional Brain Corporation Information
    • 6.10.2 Emotional Brain Description and Business Overview
    • 6.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Emotional Brain Product Portfolio
    • 6.10.5 Emotional Brain Recent Developments/Updates
  • 6.11 Ivix LLX
    • 6.11.1 Ivix LLX Corporation Information
    • 6.11.2 Ivix LLX Sexual Dysfunction Drugs Description and Business Overview
    • 6.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Ivix LLX Product Portfolio
    • 6.11.5 Ivix LLX Recent Developments/Updates
  • 6.12 Leadiant Biosciences
    • 6.12.1 Leadiant Biosciences Corporation Information
    • 6.12.2 Leadiant Biosciences Sexual Dysfunction Drugs Description and Business Overview
    • 6.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Leadiant Biosciences Product Portfolio
    • 6.12.5 Leadiant Biosciences Recent Developments/Updates
  • 6.13 NexMed
    • 6.13.1 NexMed Corporation Information
    • 6.13.2 NexMed Sexual Dysfunction Drugs Description and Business Overview
    • 6.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 NexMed Product Portfolio
    • 6.13.5 NexMed Recent Developments/Updates
  • 6.14 S1 Biopharma
    • 6.14.1 S1 Biopharma Corporation Information
    • 6.14.2 S1 Biopharma Sexual Dysfunction Drugs Description and Business Overview
    • 6.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 S1 Biopharma Product Portfolio
    • 6.14.5 S1 Biopharma Recent Developments/Updates
  • 6.15 Vietstar Biomedical Research
    • 6.15.1 Vietstar Biomedical Research Corporation Information
    • 6.15.2 Vietstar Biomedical Research Sexual Dysfunction Drugs Description and Business Overview
    • 6.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Vietstar Biomedical Research Product Portfolio
    • 6.15.5 Vietstar Biomedical Research Recent Developments/Updates

7 Sexual Dysfunction Drugs Manufacturing Cost Analysis

  • 7.1 Sexual Dysfunction Drugs Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Sexual Dysfunction Drugs
  • 7.4 Sexual Dysfunction Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Sexual Dysfunction Drugs Distributors List
  • 8.3 Sexual Dysfunction Drugs Customers

9 Sexual Dysfunction Drugs Market Dynamics

  • 9.1 Sexual Dysfunction Drugs Industry Trends
  • 9.2 Sexual Dysfunction Drugs Growth Drivers
  • 9.3 Sexual Dysfunction Drugs Market Challenges
  • 9.4 Sexual Dysfunction Drugs Market Restraints

10 Global Market Forecast

  • 10.1 Sexual Dysfunction Drugs Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Sexual Dysfunction Drugs by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Sexual Dysfunction Drugs by Type (2022-2027)
  • 10.2 Sexual Dysfunction Drugs Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Sexual Dysfunction Drugs by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Sexual Dysfunction Drugs by Application (2022-2027)
  • 10.3 Sexual Dysfunction Drugs Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Sexual Dysfunction Drugs by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Sexual Dysfunction Drugs by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Oral Therapy
    Intracavernosal Therapy
    Hormonal Therapy
    Transurethral Therapy

    Segment by Application
    Male
    Female

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Pfizer
    GlaxoSmithKline
    Merck
    Eli Lilly
    AbbVie
    Bayer
    Teva Pharmaceutical Industries
    Takeda
    Apricus Biosciences
    Emotional Brain
    Ivix LLX
    Leadiant Biosciences
    NexMed
    S1 Biopharma
    Vietstar Biomedical Research

    Buy now